Nova Patents
AT286398T

Desmethylolanzapine compositions and methods

Abstract

The use of desmethylolanzapine or a salt thereof acceptable from the pharmaceutical point of view for the manufacture of a medicament for the treatment of psychosis in humans.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

17 members in 11 offices

This recordMember, by publication datePriority claim1 more office is in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
10958498United States of AmericaP
9927647United States of AmericaW

Members17

Family members, oldest first
DocumentOfficeKind
CA2351718A1CanadaA1
WO0030650A1World Intellectual Property Organization (WIPO)A1
AU1741600AAustraliaA
EP1133300A1European Patent Office (EPO)A1
US6348455B1United States of AmericaB1
US2002082251A1United States of AmericaA1
JP2002530341AJapanA
US6468997B2United States of AmericaB2
AU757973B2AustraliaB2
EP1133300B1European Patent Office (EPO)B1
AT286398TThis recordAustriaT
ATE286398T1AustriaT1
DE69923081D1GermanyD1
PT1133300EPortugalE
DK1133300T3DenmarkT3
ES2237188T3SpainT3
DE69923081T2GermanyT2